Stockscreener 앱 받기
1.14
5.00%
-0.06
시간 외 거래:
1.13
-0.01
-0.88%
전일 마감가:
$1.20
열려 있는:
$1.2
하루 거래량:
194.04K
Relative Volume:
1.24
시가총액:
$41.69M
수익:
-
순이익/손실:
$-9.16M
주가수익비율:
-2.00
EPS:
-0.57
순현금흐름:
$-8.75M
1주 성능:
-5.79%
1개월 성능:
-12.31%
6개월 성능:
-1.72%
1년 성능:
-1.72%
1일 변동 폭
$1.11
$1.215
1주일 범위
$1.11
$1.2752
52주 변동 폭
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
명칭
Renovorx Inc
전화
408-800-2649
주소
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
RNXT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.14 | 43.89M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovorx Inc 주식(RNXT)의 최신 뉴스
Signal strength of RenovoRx Inc. stock in tech scannersHigh Yield Signals with Entry Timing - Newser
Is this a good reentry point in RenovoRx Inc.Triple Digit Gain Opportunity Watchlist - Newser
Can trapped investors hope for a rebound in RenovoRx Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
What makes RenovoRx Inc. stock price move sharplyEntry Opportunity Screener with Confirmation - Newser
RenovoRx Inc. Breakout Confirmed by Volume MetricsGrowth Based Investment Plan Guidance Highlighted - beatles.ru
What data driven models say about RenovoRx Inc.’s futureTrading Watchlist with Real Time Filters - Newser
Heatmap analysis for RenovoRx Inc. and competitorsWeekly Market Direction and Sector Summary - Newser
Published on: 2025-08-08 23:06:33 - Newser
Why RenovoRx Inc. stock attracts strong analyst attentionFree Low Risk Picks for Daily Trading - Newser
Visual trend scoring systems applied to RenovoRx Inc.Free Fast Gaining Stock Screener Report - Newser
Using Ichimoku Cloud for RenovoRx Inc. technicalsPredictive Screener for Daily Trade Watch - Newser
RenovoRx CEO Finds Disconnect with Wall Street, Sees Undervalued Shares - AInvest
RenovoRx CEO Shaun Bagai on Targeted Oncology Therapies, Commercialization Progress, and Phase III TIGeR-PaC Clinical Trial. - AInvest
Meet RenovoRx: Fly exclusive interview with CEO Shaun Bagai - TipRanks
RenovoRx (RNXT) to Release Quarterly Earnings on Thursday - Defense World
Is RenovoRx Inc. trending in predictive chart modelsAI Enhanced Strategy for Portfolio Growth - Newser
RenovoRx expands commercial footprint to 13 cancer centers By Investing.com - Investing.com South Africa
RenovoRx expands commercial footprint to 13 cancer centers - Investing.com
RenovoRx Expands Commercial Footprint with Key Leadership Hire and Growing Demand for RenovoCath Device - AInvest
RenovoCath Cancer Device Adoption Triples at Leading Cancer Centers | RNXT Stock News - Stock Titan
Will RenovoRx Inc. price bounce be sustainableFree Short Term Trading Opportunity Watch - Newser
Can you recover from losses in RenovoRx Inc.Top Stock Picks with Forecast Accuracy - Newser
RenovoRx Inc. Testing Reversal Zone on Weekly ChartROI Driven Equity Selection With Safety Emphasized - metal.it
Is RenovoRx Inc. stock bottoming outFree Community Strategy With High Win Rate - Newser
Is RenovoRx Inc. a growth stock or a value stockBreakthrough capital growth - Jammu Links News
What analysts say about RenovoRx Inc. stockUnlock powerful trading alerts for success - Jammu Links News
What is RenovoRx Inc. company’s growth strategyHigh-octane financial growth - Jammu Links News
Published on: 2025-08-04 04:04:54 - Jammu Links News
How volatile is RenovoRx Inc. stock compared to the marketGet timely market insights for better trades - Jammu Links News
What are analysts’ price targets for RenovoRx Inc. in the next 12 monthsUnlock steady growth with low-risk stocks - Jammu Links News
How does RenovoRx Inc. generate profit in a changing economyAccelerated profit realization - Jammu Links News
What are RenovoRx Inc. company’s key revenue driversGet daily expert analysis on top stocks - Jammu Links News
What are the technical indicators suggesting about RenovoRx Inc.Breakneck growth rates - Jammu Links News
Is RenovoRx Inc. stock overvalued or undervaluedAchieve rapid portfolio appreciation today - Jammu Links News
What drives RenovoRx Inc. stock priceOutstanding stock performance - Jammu Links News
When is RenovoRx Inc. stock expected to show significant growthUnlock market-leading stock analysis - Jammu Links News
Should I hold or sell RenovoRx Inc. stock in 2025Outstanding stock performance - Jammu Links News
What catalysts could drive RenovoRx Inc. stock higher in 2025Accelerated investment success - Jammu Links News
What institutional investors are buying RenovoRx Inc. stockUnlock powerful trading alerts for success - Jammu Links News
RenovoRx (NASDAQ:RNXT) Rating Lowered to Sell at Wall Street Zen - Defense World
Earnings Preview For RenovoRx - 富途牛牛
Exit strategy if you’re trapped in RenovoRx Inc.Swing Trade Entry and Exit Point Analysis - Newser
Will RenovoRx Inc. stock recover after recent dropMinimal Risk Growth Investment Opportunity Analysis - Newser
How RenovoRx Inc. stock performs during market volatilityPattern Breakout Tracker with Screener Tools - Newser
Renovorx Inc (RNXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):